Pakistan Revenue
KARACHI, May 6, 2026 — GlaxoSmithKline Pakistan Limited expects tax relief for the pharmaceutical sector in the upcoming federal budget 2026-27, citing pressure on profitability from the current high-tax regime, company officials said on Wednesday.
Continue Reading
Karachi, March 24, 2025 – GlaxoSmithKline Pakistan Limited has announced an extraordinary surge in its profit after tax (PAT), registering a staggering 1124% increase for the year ending December 31, 2024.
Continue Reading
Karachi, April 23, 2024 – GlaxoSmithKline (GSK) Pakistan announced plans to challenge a recent decision by the Drug Court in Rawalpindi, which found certain current and former company officials guilty under the Drugs Act of 1976 for distributing sub-standard drugs.
Continue Reading
Karachi, April 3, 2024 – GlaxoSmithKline (GSK) Pakistan’s Chairperson, Lai Kuen Goh, has disclosed a significant decline in the company’s gross margin by 10 percent, attributing it to the prevailing economic conditions in the country.
Continue Reading
GSK Pakistan has been re-certified by The Top Employers Institute as a top employer 2023 for the third consecutive year.
Continue Reading
GlaxoSmithKline Pakistan on Friday declared force majeure due to negative margins for manufacturing of Panadol tablets in the country. The company in a statement said we are one of the few multinational companies left operating in the country. However, due to the challenges stated above, manufacturing of the Panadol range on negative margins is unsustainable, […]
Continue Reading
KARACHI: GlaxoSmithKline (GSK) on Friday confirmed that government authorities raided one of its warehouses related to shortage of Panadol. According to information received by Pakistan Stock Exchange (PSX), the company confirmed the raid to one of its warehouses. “We firmly reject the claims related to the hoarding of Panadol intentionally to create shortage,” said Farhan […]
Continue Reading
KARACHI: GlaxoSmithKline (GSK) Consumer Healthcare Pakistan Limited has rejected allegations and said consumer health is its top priority. In a communication sent to Pakistan Stock Exchange (PSX) on May 20, 2022, the company said about the allegations made by the Young Pharmacists Association against DRAP, GSK and various other organisations etc. While we see no […]
Continue Reading
KARACHI: Aziz ul Huq, Chief Executive Officer of GlaxoSmithKline Pakistan Limited has resigned for personal reasons and the board of directors of the company appointed Ms. Erum Shakir Rahim as new CEO of the company from March 01, 2020. In a notice to Pakistan Stock Exchange (PSX) on Thursday, the company said that Aziz ul […]
Continue Reading